Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Cadrenal Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is John P. Sharp, Chief Financial Officer (Form 8-K filed 2026-06-29). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names The Pnc Financial Services Group, Inc. (filed 2026-08-07).
Who is behind it
Cadrenal Therapeutics, Inc.: incorporated in Delaware; business address in Ponte Vedra, Florida; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-07).
Officers and directors, each with the role and the filing that names them:
- Quang X. Pham: Executive Officer, Director (Form D, 2026-07-15)
- John P. Sharp: Executive Officer (Form D, 2026-07-15)
- James J. Ferguson: Executive Officer (Form D, 2026-07-15)
- Jeffrey S. Cole: Executive Officer (Form D, 2026-07-15)
- Lee Golden: Director (Form D, 2026-07-15)
- John R. Murphy: Director (Form D, 2026-07-15)
- Glynn Wilson: Director (Form D, 2026-07-15)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-07 | The Pnc Financial Services Group, Inc. | 8.13% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-29 | John P. Sharp | Chief Financial Officer | appointed | |
| Form 8-K, 2026-06-29 | Steven Zelenkofske | Director | departed | 2026-06-30 |
| Form 8-K, 2026-06-29 | Glynn Wilson | Director | departed | |
| Form 8-K, 2026-06-03 | Quang X. Pham | Chief Financial Officer | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-07-15 | $8.84M | $8.84M |
| Form D, 2026-04-06 | $7.92M | $7.92M |
| Form D, 2025-12-31 | $4.40M | $4.40M |
| Form D, 2024-11-14 | $9.43M | $9.43M |
| Form D, 2023-07-18 | $7.50M | $7.50M |
| Form D, 2022-12-08 | $250K | $1M |
Latest IPO step: Cadrenal Therapeutics, Inc. filed to go public (S-1, 2025-12-29).
IPO filings: S-1, 2025-12-29; ticker CVKD on Nasdaq Capital Market.
Related pages
Funding and filing historyLeadership changes5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/cadrenal-therapeutics-incLast updated 2026-10-18
Primary record: Schedule 13G, 2026-08-07 · Form D, 2026-07-15 · Form 8-K, 2026-06-29 · Form 8-K, 2026-06-03
Who owns Cadrenal Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/cadrenal-therapeutics-inc